Effect of Supra Choroid Triamcinolone Acetate On Intraocular Pressure

Supra Choroid Triamcinolone Acetate for Intraocular Pressure

Authors

  • Sohail Bukhari Department of Ophthalmology, AL Ibrahim Eye Hospital, Karachi, Pakistan
  • Uzma Haseeb Department of Ophthalmology, AL Ibrahim Eye Hospital, Karachi, Pakistan
  • Nasir Ahmed Department of Ophthalmology, AL Ibrahim Eye Hospital, Karachi, Pakistan
  • Israr Ahmed Department of Ophthalmology, AL Ibrahim Eye Hospital, Karachi, Pakistan
  • Shoaib Ahmed Department of Ophthalmology, AL Ibrahim Eye Hospital, Karachi, Pakistan
  • Shahid Hussain Shah Department of Ophthalmology, AL Ibrahim Eye Hospital, Karachi, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v6i1.2087

Keywords:

Corticosteroids, Intraocular Pressure, Triamcinolone, Supra-Choroidal Space

Abstract

Intraocular pressure is a critical parameter in maintaining the physiological function of the eye. Dysregulation of Intraocular pressure can lead to ocular pathologies. Objective: To evaluate change in intraocular pressure after supra-choroidal triamcinolone acetonide use. Methods: This prospective interventional studyas carried out at the vitreo-retina Department of Al Ibrahim Eye Hospital Karachi, ISRA Postgraduate Institute of Ophthalmology for six months from July to December 2023. Adult patients attending the vitreoretinal Outpatient Department with resistant macular oedema were included. Intraocular pressure readings at 1 week, 4 weeks, 8 weeks and 12 weeks were recorded and compared with baseline values by applying One-way ANOVA keeping the p-value of <0.05 as statistically significant. Data were analyzed using SPSS v 22.0. Results: Among all, 21 (46.67%) cases received injections to the right eye and 24 (53.33%) cases to the left eye. The mean intraocular pressure before injection was 12.07 ± 2.14 mmHg. At three months’ post-injection, the mean intraocular pressure was 13.60 ± 5.2 mmHg. For the right eye; the mean pre-injection intraocular pressure was 12.38 ± 1.96 mmHg. Three months’ post-injection, the mean intraocular pressure was 13.43 ± 5.59 mmHg (p<0.001). For the left eye; the mean pre-injection intraocular pressure was 11.79 ± 2.28 mmHg while three months’ post-injection, the mean intraocular pressure was 13.75 mmHg ± 4.96 (p-0.06). Conclusions: It was concluded that supra-choroidal triamcinolone injections increase intraocular pressure but stabilized over time. These findings support earlier trials and add to the evidence of this therapy's efficacy and safety.

References

Campochiaro PA, Wykoff CC, Brown DM, Boyer DS, Barakat M, Taraborelli D et al. Supra-choroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study. Ophthalmology Retina. 2018 Apr; 2(4): 320-8. doi: 10.1016/j.oret.2017.07.013.

Habot‐Wilner Z, Noronha G, Wykoff CC. Supra-choroidally Injected Pharmacological Agents for the Treatment of Chorio‐Retinal Diseases: A Targeted Approach. Acta Ophthalmologica. 2019 Aug; 97(5): 460-72. doi: 10.1111/aos.14042.

Wykoff CC, Khurana RN, Lampen SI, Noronha G, Brown DM, Ou WC et al. Supra-Choroidal Triamcinolone Acetonide for Diabetic Macular Edema: The HULK Trial. Ophthalmology Retina. 2018 Aug; 2(8): 874-7. doi: 10.1016/j.oret.2018.03.008.

Bhattacharyya S, Hariprasad SM, Albini TA, Dutta SK, John D, Padula WV et al. Supra-choroidal Injection of Triamcinolone Acetonide Injectable Suspension for the Treatment of Macular Edema Associated with Uveitis in the United States: A Cost-Effectiveness Analysis. Value in Health. 2022 Oct; 25(10): 1705-16. doi: 10.1016/j.jval.2022.07.008.

Yousef MS, Abd Elhafez YA, Farag MH. Assessment of Supra-Choroidal Injection of Triamcinolone Acetonide in Cases of Diabetic Macular Edema. International Journal of Medical Arts. 2021 Apr; 3(2): 1384-9. doi: 10.21608/ijma.2021.55079.1230.

Thomas J, Kim L, Albini T, Yeh S. Triamcinolone Acetonide Injectable Suspension for Suprachoroidal Use in The Treatment of Macular Edema Associated with Uveitis. Expert Review of Ophthalmology. 2022 May; 17(3): 165-73. doi: 10.1080/17469899.2022.2114456.

Kim TK, Shin HY, Kim SY, Lee YC, Lee MY. Factors Influencing Intra-vitreal Bevacizumab and Triamcinolone Treatment in Patients with Diabetic Macular Edema. European Journal of Ophthalmology. 2017 Nov; 27(6): 746-50. doi: 10.5301/ejo.5000974.

Rahman S, Tayyab H, Siddiqui MR. Supra-Choroidal Triamcinolone Acetonide Injection to Treat Macular Edema: A Review. Journal of Vitreo Retinal Diseases. 2024 Nov; 8(6): 699-708. doi: 10.1177/24741264241275271.

Fatima M, Abbas S, Sajjad T. Efficacy and Safety of Triamcinolone Acetonide Injection in Supra-Choroidal Space. Biological and Clinical Sciences Research Journal. 2023: 290. doi: 10.54112/bcsrj.v2023i1.290.

Fung S and Syed YY. Supra-Choroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema. Drugs. 2022 Sep; 82(13): 1403-10. doi: 10.1007/s40265-022-01777-1.

Ghazanfar AS, Khowaja AH, Tayyab H. Effect of Supra-Choroidal Triamcinolone On Intraocular Pressure: A Systematic Review and Meta-Analysis. Therapeutic Advances in Ophthalmology. 2024 Feb; 16: 25158414241228671. doi: 10.1177/25158414241228671.

Roberti G, Oddone F, Agnifili L, Katsanos A, Michelessi M, Mastropasqua L et al. Steroid-Induced Glaucoma: Epidemiology, Pathophysiology, and Clinical Management. Survey of Ophthalmology. 2020 Jul; 65(4): 458-72. doi: 10.1016/j.survophthal.2020.01.002.

Singer MA, Merrill P, Yeh S, Hall C, Kapik B, Ciulla TA. Supra-Choroidal Triamcinolone Acetonide Versus Rescue Therapies for the Treatment of Uveitic Macular Oedema: A Post Hoc Analysis of PEACHTREE. Clinical and Experimental Ophthalmology. 2022 Jan; 50(1): 23-30. doi: 10.1111/ceo.14024.

Jung JH, Chae JJ, Prausnitz MR. Targeting Drug Delivery Within the Supra-Choroidal Space. Drug Discovery Today. 2019 Aug; 24(8): 1654-9. doi: 10.1016/j.drudis.2019.03.027.

Aslam M, Nazir T, Haq RI, Asghar A, Nadeem S, Obaid N. Efficacy of Supra-Choroidal Versus Intra-vitreal Triamcinolone Acetonide in Refractory Macular Edema; A Quasi-experimental study. Pakistan Armed Forces Medical Journal. 2024 Oct1; 74(5): 1365. doi: 10.51253/pafmj.v74i5.10818.

Wu KY, Fujioka JK, Gholamian T, Zaharia M, Tran SD. Supra-Choroidal Injection: A Novel Approach for Targeted Drug Delivery. Pharmaceuticals. 2023 Sep; 16(9): 1241. doi: 10.3390/ph16091241.

Tayyab H, Ahmed CN, Sadiq MA. Efficacy and Safety of Supra-Choroidal Triamcinolone Acetonide in Cases of Resistant Diabetic Macular Edema. Pakistan Journal of Medical Sciences. 2020 Jan; 36(2): 42. doi: 10.12669/pjms.36.2.1194.

Wan CR, Muya L, Kansara V, Ciulla TA. Supra-Choroidal Delivery of Small Molecules, Nanoparticles, Gene and Cell Therapies for Ocular Diseases. Pharmaceutics. 2021 Feb; 13(2): 288. doi: 10.3390/pharmaceutics13020288.

Zakaria YG, Salman AG, Said AM, Abdelatif MK. Supra-Choroidal Versus Intra-Vitreal Triamcinolone Acetonide for the Treatment of Diabetic Macular Edema. Clinical Ophthalmology. 2022 Mar: 733-46. doi: 10.2147/OPTH.S351853.

Ateeq A, Majid S, Memon NA, Hayat N, Somroo AQ, Fattah A. Supra-Choroidal Injection of Triamcinolone Acetonide for Management of Resistant Diabetic Macular Oedema. The Journal of the Pakistan Medical Association. 2023 Feb; 73(2): 239-44. doi: 10.47391/JPMA.2239.

Yeh S, Khurana RN, Shah M, Henry CR, Wang RC, Kissner JM et al Efficacy and Safety of Supra-choroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3 Randomized Trial. Ophthalmology. 2020 Jul; 127(7): 948-55. doi: 10.1016/j.ophtha.2020.01.006.

Zhang DD, Che DY, Zhu DQ. A Simple Technique for Supra-Choroidal Space Injection of Triamcinolone Acetonide in the Treatment of Macular Edema. International Journal of Ophthalmology. 2022; 15(12): 2017. doi: 10.18240/ijo.2022.12.18.

Abdelshafy Tabl A, Tawfik Soliman T, Anany Elsayed M, Abdelshafy Tabl M. A Randomized Trial Comparing Supra-choroidal and Intra-vitreal Injection of Triamcinolone Acetonide in Refractory Diabetic Macular Edema Due to Epiretinal Membrane. Journal of Ophthalmology. 2022; 2022(1): 7947710. doi: 10.1155/2022/7947710.

Munir MS, Rehman R, Nazir S, Sharif N, Chaudhari MZ, Saleem S. Visual Outcome after Suprachoroidal Injection of Triamcinolone Acetate in Cystoid Macular Edema of Different Pathology. Pakistan Journal of Medical and Health Sciences. 2022 May; 16(05): 164-. doi: 10.53350/pjmhs22165164.

Ali BM, Azmeh AM, Alhalabi NM. Supra-Choroidal Triamcinolone Acetonide for the Treatment of Macular Edema Associated with Retinal Vein Occlusion: A Pilot Study. BioMed Central Ophthalmology. 2023 Feb; 23(1): 60. doi: 10.1186/s12886-023-02808-5.

Downloads

Published

2025-01-31
CITATION
DOI: 10.54393/pjhs.v6i1.2087
Published: 2025-01-31

How to Cite

Bukhari, S., Haseeb, U., Ahmed, N., Ahmed, I., Ahmed, S., & Shah, S. H. (2025). Effect of Supra Choroid Triamcinolone Acetate On Intraocular Pressure: Supra Choroid Triamcinolone Acetate for Intraocular Pressure. Pakistan Journal of Health Sciences, 6(1), 152–156. https://doi.org/10.54393/pjhs.v6i1.2087

Issue

Section

Original Article

Plaudit

Most read articles by the same author(s)